Skip to main content
Erschienen in: Virchows Archiv 1/2007

01.07.2007 | Original Article

Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma

verfasst von: A. B. Soares, P. B. Juliano, V. C. Araujo, K. Metze, A. Altemani

Erschienen in: Virchows Archiv | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

We analyzed the tumor vascularization in carcinomas ex-pleomorphic adenoma (CXPA) to investigate the angiogenic switch during the malignant transformation of pleomorphic adenoma (PA) to carcinoma and during tumor progression. In eight cases of early CXPA (intracapsular and minimally invasive tumors), eight of advanced CXPA (widely invasive tumors), and ten of PA without malignant transformation, tumor vascularization was assessed in histological samples by measuring total microvascular area (TVA) and microvessel density (MVD) using CD34 and CD105 antibodies. MVD for CD105 increased significantly during tumor progression, whereas this was not the case for CD34 MVD. Comparing widely invasive CXPA with and without myoepithelial differentiation, CXPA with myoepithelial differentiation showed a significantly lower number of CD105 positive vessels but revealed higher TVA values. In these tumors, the neoplastic cells usually formed larger hypovascularized aggregates that were often surrounded by large-sized vessels. In conclusion, the antibody CD105 reveals an angiogenic switch during the progression from adenoma to carcinoma in salivary glands. The degree of angiogenesis and the total vascular area have distinctive patterns in CXPA with and without myoepithelial differentiation. Low angiogenesis associated with high TVA value is more characteristic of CXPA with myoepithelial differentiation.
Literatur
1.
Zurück zum Zitat Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T (2002) Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131:109–113CrossRef Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T (2002) Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131:109–113CrossRef
2.
Zurück zum Zitat Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC (2005) Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 46:635–641PubMedCrossRef Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC (2005) Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 46:635–641PubMedCrossRef
3.
Zurück zum Zitat Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesion. Human Pathol 37:861–866CrossRef Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesion. Human Pathol 37:861–866CrossRef
4.
Zurück zum Zitat Diodoro MG, Di Carlo E, Zappacosta R, Iezzi M, Coletti A, Modesti A, D’Antuono T, Forni G, Musiani P (2000) Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. Int J Cancer 88:329–335PubMedCrossRef Diodoro MG, Di Carlo E, Zappacosta R, Iezzi M, Coletti A, Modesti A, D’Antuono T, Forni G, Musiani P (2000) Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. Int J Cancer 88:329–335PubMedCrossRef
5.
Zurück zum Zitat Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H (1999) Expression of p53 oncoprotein increase intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med 28:259–263PubMedCrossRef Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H (1999) Expression of p53 oncoprotein increase intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med 28:259–263PubMedCrossRef
6.
Zurück zum Zitat Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:948–992CrossRef Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:948–992CrossRef
7.
Zurück zum Zitat Ellis GL, Auclair PL (1996) Malignant epithelial tumors. In: Rosai J, Sobin LH (eds) Atlas of tumor pathology, series 3, section 5, fascicle 17. Armed Forces Institute of Pathology, Washington, DC, pp 155–373 Ellis GL, Auclair PL (1996) Malignant epithelial tumors. In: Rosai J, Sobin LH (eds) Atlas of tumor pathology, series 3, section 5, fascicle 17. Armed Forces Institute of Pathology, Washington, DC, pp 155–373
8.
Zurück zum Zitat Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M (2003) Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets 3:427–432PubMedCrossRef Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M (2003) Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets 3:427–432PubMedCrossRef
9.
Zurück zum Zitat Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413–430PubMedCrossRef Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413–430PubMedCrossRef
10.
Zurück zum Zitat Gnepp DR (1993) Malignant mixed tumors of the salivary:glands a review. Pathol Annu 28:279–328PubMed Gnepp DR (1993) Malignant mixed tumors of the salivary:glands a review. Pathol Annu 28:279–328PubMed
11.
Zurück zum Zitat Gnepp DR, Brandwein MS, Henley JD (2000) Salivary and lacrimal glands. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck. W.B. Saunders, Philadelphia, pp 325–430 Gnepp DR, Brandwein MS, Henley JD (2000) Salivary and lacrimal glands. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck. W.B. Saunders, Philadelphia, pp 325–430
13.
Zurück zum Zitat Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 94:883–893PubMed Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 94:883–893PubMed
14.
Zurück zum Zitat Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, Thomas-Tsagli E, Davaris P (2001) Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 438:6036–6611CrossRef Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, Thomas-Tsagli E, Davaris P (2001) Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 438:6036–6611CrossRef
15.
Zurück zum Zitat Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P (2002) Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 28:57–66PubMedCrossRef Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P (2002) Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 28:57–66PubMedCrossRef
16.
Zurück zum Zitat Laitakari J, Nayha V, Stenback F (2004) Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol 57:394–401PubMedCrossRef Laitakari J, Nayha V, Stenback F (2004) Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol 57:394–401PubMedCrossRef
17.
Zurück zum Zitat Lewis JE, Olsen KD, Sebo TJ (2001) Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 32:596–604PubMedCrossRef Lewis JE, Olsen KD, Sebo TJ (2001) Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 32:596–604PubMedCrossRef
18.
Zurück zum Zitat Livolsi VA, Perzin KH (1977) Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 39:2209–2230PubMedCrossRef Livolsi VA, Perzin KH (1977) Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 39:2209–2230PubMedCrossRef
19.
Zurück zum Zitat Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 44:127–134CrossRef Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 44:127–134CrossRef
20.
Zurück zum Zitat Nathonson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423CrossRef Nathonson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423CrossRef
21.
Zurück zum Zitat Nguyen M, Lee MC, Wang JL, Tomlinson JS, Shao ZM, Alpaugh ML, Barsky SH (2000) The human myopithelial cell displays a multifaceted anti-angoigenic phenotype. Oncogene 19:3449–3459PubMedCrossRef Nguyen M, Lee MC, Wang JL, Tomlinson JS, Shao ZM, Alpaugh ML, Barsky SH (2000) The human myopithelial cell displays a multifaceted anti-angoigenic phenotype. Oncogene 19:3449–3459PubMedCrossRef
22.
Zurück zum Zitat Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter KC, Harris AL, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1:1417–1423 Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter KC, Harris AL, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1:1417–1423
23.
Zurück zum Zitat Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA (1998) The EnVision™+ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate™, CSA, LABC and SABC techniques. J Clin Pathol 51:506–511PubMedCrossRef Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA (1998) The EnVision™+ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate™, CSA, LABC and SABC techniques. J Clin Pathol 51:506–511PubMedCrossRef
24.
Zurück zum Zitat Sharma S, Sharma MC, Sarkar C (2005) Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46:481–489PubMedCrossRef Sharma S, Sharma MC, Sarkar C (2005) Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46:481–489PubMedCrossRef
25.
Zurück zum Zitat Sternlicht MD, Barsky SH (1997) The myoepithelial defense: a host defense against cancer. Med Hypotheses 48:37–46PubMedCrossRef Sternlicht MD, Barsky SH (1997) The myoepithelial defense: a host defense against cancer. Med Hypotheses 48:37–46PubMedCrossRef
26.
Zurück zum Zitat Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T (2005) Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 446:653–662PubMedCrossRef Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T (2005) Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 446:653–662PubMedCrossRef
27.
Zurück zum Zitat Tanaka F, Otake Y, Yanagihara K, kawano Y, Miyahara R, Li M, Ishikawa S, Wada H (2003) Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis. Lung Cancer 39:289–296PubMedCrossRef Tanaka F, Otake Y, Yanagihara K, kawano Y, Miyahara R, Li M, Ishikawa S, Wada H (2003) Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis. Lung Cancer 39:289–296PubMedCrossRef
28.
Zurück zum Zitat Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579PubMedCrossRef Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579PubMedCrossRef
29.
Zurück zum Zitat Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD (1993) A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 54:363–370PubMedCrossRef Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD (1993) A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 54:363–370PubMedCrossRef
30.
Zurück zum Zitat Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11:7334–7743PubMedCrossRef Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11:7334–7743PubMedCrossRef
Metadaten
Titel
Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma
verfasst von
A. B. Soares
P. B. Juliano
V. C. Araujo
K. Metze
A. Altemani
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 1/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0438-z

Weitere Artikel der Ausgabe 1/2007

Virchows Archiv 1/2007 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …